Skip to content

Effects of different doses of Esketamine on postpartum depression in cesarean section under general anesthesia

Effects of different doses of Esketamine on postpartum depression in cesarean section under general anesthesia

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052505
Enrollment
Unknown
Registered
2021-10-30
Start date
2021-11-10
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum depression

Interventions

experimental group 1:Esketamine 0.25mg/kg iv
experimental group 2:Esketamine 0.5mg/kg iv
control group:NS 10ml iv

Sponsors

Chengdu Women and Children's Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged from 25 to 35 years for cesarean section under general anesthesia; 2. ASA I-II; 3. Weight 60-85kg, singleton, gestational age 37-41 weeks; 4. One day before the operation, the maternal was evaluated by the depression Self-rating Scale, and the score was <0.6 5. Mallampati I-III; 6. Ultrasound examination showed that the fetus was developing normally.

Exclusion criteria

Exclusion criteria: 1. Patients with difficult airway, heart function grade III or above, complicated with serious lung disease; 2. Long-term use of narcotic analgesics, sedatives or non-steroidal anti-inflammatory drugs; 3. Patients with contraindications to general anesthesia; 4. Patients who are allergic to any of the investigational drugs; 5. Patients with contraindications for experimental drugs were satisfied; 6. Participated in drug clinical trials as a subject within the last 3 months; 7. Patients with cognitive dysfunction or mental or neurological dysfunction unable to match the pain score.

Design outcomes

Primary

MeasureTime frame
Edinburgh score;

Countries

China

Contacts

Public ContactLi Weina

Chengdu Women and Children's Central Hospital

897711502@qq.com+86 19983132872

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026